Model for end-stage liver disease: end of the first decade
- PMID: 22032523
- PMCID: PMC3564596
- DOI: 10.1016/j.cld.2011.08.009
Model for end-stage liver disease: end of the first decade
Abstract
The Model for End-stage Liver Disease (MELD) score is the basis for allocation of liver allografts for transplantation in the United States. The MELD score, as an objective scale of disease severity, is also used in the management of patients with chronic liver disease in the nontransplant setting. Several models have been proposed to improve the MELD score. The authors believe that the MELD score is, by design, continually evolving and lends itself to continued refinement and improvement to serve as a metric to optimize organ allocation in the future.
Copyright © 2011 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
References
-
- Olthoff KM, Brown RS, Jr, Delmonico FL, et al. Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington DC, USA. Liver Transpl. 2004;10(10) Suppl 2:A6–A22. - PubMed
-
- Freeman RB, Wiesner RH, Edwards E, et al. Results of the first year of the new liver allocation plan. Liver Transpl. 2004;10(1):7–15. - PubMed
-
- Kamath PS, Kim WR. The model for end-stage liver disease (MELD) Hepatology. 2007;45(3):797–805. - PubMed
-
- Freeman RB., Jr Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card. Hepatology. 2008;47(3):1052–1057. - PubMed
-
- Lake JR. MELD--an imperfect, but thus far the best, solution to the problem of organ allocation. J Gastrointestin Liver Dis. 2008;17(1):5–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
